DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20164084

Spurious drugs: do we neglect during our clinical practice? a systematic review

E. Manivannan, V. Sivasankari

Abstract


Spurious drugs are those manufactured by concealing the identity of the true ones. It forms one of the largest growing markets in India. The aim of this review is to create an awareness of the prescribing doctors that substandard or fraudulent drugs are widely prevalent and it is in our doorstep during the regular practice. The duty of the prescriber is to identify these drugs, share the information’s to the fellow colleagues and avoid them from prescribing. It is the role of the physicians to intimate this information to the patients also who consumes these drugs due to lack of awareness as like food products which are consumed as an adulterant one. We the health care professionals carry the duty of identifying these spurious drugs being manufactured and marketed by unlicensed or licensed pharmaceutical companies which are hazardous to our patient’s health. All the data’s about this misbranded drugs are gathered from Journals and related websites from 2000-2016, thereby complied to reveal the present situation of spurious drugs. The Government of India has taken steps to implement Cosmetics Act 1940 and special courts are set up for speedy disposal of these related cases. Also the Government in its part announced the “Whistle Blower Scheme” to encourage the public to be vigilant and report the widespread infiltration of spurious drugs in the market and to receive the cash reward for this information.


Keywords


Cosmetics Act 1940, Fraudulent drug, Spurious drugs, Whistle blower scheme

Full Text:

PDF

References


Ministry of Health and Family Welfare; 2005. [Last cited on 2014 Oct 14] Government of India, Drugs and Cosmetic Rules (Amendment) Available from: http://www.cdsco.inc.in./forms/contentpage 1.aspx? Lid=1888.

New Delhi: Ministry of Health and Family Welfare, Government of India; 2009. [Last cited on 2013 Nov 20]. CSDCCO. Report on countrywide survey for spurious drugs; pp. 3-4. Available from: http://www.cdsco.nic.in/report_book_13-7-10.pdf.

Srinivasan S. Indian Journal of Medical Ethics. 2010;7(3).

India: All India Drug Action Network 2014 posted on August 20, 2014. Towards a people oriented, rational drug policy.https//aidain.india.word press.com.

Sagar BPS, Zafar R, Singh A. Counterfeit, Fake, Spurious drugs. Health Administrator. 2006;1:55-73.

Drug and Cosmetic Act available at http://www.cdsco.nic.in/forms/contentpage1.aspx?lid=1888 th (Latest access: 09 October 2014).

Central Drugs Standard Control Organization (Directorate General of Health services) Ministry of & Family Welfare, Chandigarh - Details of Samples tested during the last 3-financial years in all 7- Drug Testing Laboratories of CDSCO. Available at: the http://www.cdsco.nic.in/writereaddata/lab%20data.pdf (Latest access: 09 October 2014)

Ministry of Health & Family Welfare – Reward Scheme for Whistle blowers in the fight against the menace of spurious or fake drugs, cosmetics and medical devices. Available at: the http://www.cdsco.nic.in/writereaddata/Whistle%20Blower%20Scheme.pdf (Latest access: 09 October 2014)

CDSCO Ministry of Health and Family Welfare [last updated on 1.1.2016] Government of India. Available from www.cdsco.nic.in/forms/list.aspx?lid.

India: Daily Excelsior. Com. 2013 [Last cited on 2016. Available from.www.dailyexcelsior.com/230084-spurious drugs consumed by the patients in JK.

Dutta N. Kashmir fake drug scam: were spurious drugs responsible for high infant deaths last year? 2013 [Last cited on 2013 Apr24]. Available from:htpp://www.health.india.com/news/Kashmir-fake-drug-scam-were-spurious drugs responsible-for-high-infant-deaths-last-year/.

Drug control. Spurious drug News. 2013. [Last cited on 2013 march 5]. Available from http://www.drugscontrol.org/spurious drugs.htm.

Chatterjee P. India’s trade in fake drugs-bringing the counterfeiter’s to book” Lancet. 2001;357(9270).

Khan AH, Khar RK. Current scenario of spurious and substandard medicines in India. Generic Medicines. Press information Bureau of India; 2012. [Last cited on 2013 Jan 8] PIB, Available from: http://www.pib.nic.in/newsite/erelease.aspx?relid= 83323.

Initiatives, Achievements and Targets Central Drugs Standard Control Organization (2001 - 2020) http://www.cdsco.nic.in/writereaddata/CDSCO%20Initiatives%20&% 20 th Targets%20for%20website%2013-7-2012_17-07-2012.pdf (Latest access: 09 October 2014)

New Delhi: CDSCO report 2008 [Last cited on 2013 Oct Nov 13]Guidelines for taking action on samples of drugs declared spurious or not of standard quality the light of enhanced penalties under The Drug and Cosmetic (Amendment) Act;pp.1-13. Available from: http://www.cdsco.nic.in/writereaddata/Guidelines under new penal provisions 9.pdf.